Global Insulin Market for Type 1 and Type 2 Diabetes

Published Apr 01, 2025

Length 350 Pages

SKU # DAABD20406726

Description

The global insulin market for type 1 and type 2 diabetes is expected to reach USD 25.70 billion by 2032 from USD 19.06 billion in 2024, growing at a substantial CAGR of 3.9% in the forecast period of 2025 to 2032.

Market Segmentation:
Global Insulin Market for Type 1 And Type 2 Diabetes Segmentation, Type (Type 2 Diabetes and Type 1 Diabetes), Product Type (Long Acting Insulin, Rapid-Acting Insulin, Short Acting Insulin, and Others), Absorption Site (Basal, Bolus, and Others), Age Group (Adult Patients, Geriatric Patients, and Pediatric Patients), Source (Analog Insulin, Human Insulin, and Others), Delivery Method (Insulin Pens, Vial & Syringe, Insulin Pumps, Inhalable Insulin, and Implantable Insulin Delivery Systems), Gender (Male and Female), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Diabetes Clinics & Specialty Pharmacies), By Countries (U.S., Canada, Mexico, China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Indonesia, Australia, Philippines, New Zealand, Taiwan, Vietnam, Rest of Asia-Pacific, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Denmark, Norway, Poland, Rest of Europe, Brazil, Argentina, Chile, Peru, Rest of South America, South Africa, U.A.E., Egypt, Saudi Arabia, Israel, Kuwait, and Rest of Middle East and Africa)- Industry Trends and Forecast to 2032

Overview of Global Insulin Market for Type 1 and Type 2 Diabetes Dynamics:

Driver

• Rising prevalence of diabetes
Restraint

• Adverse effects of high dosage of insulin

Opportunity

• Advancements in insulin formulation and delivery technologies
Market Players:

The key market players operating in the global insulin market for type 1 and type 2 diabetes are listed below:

• Novo Nordisk A/S (Denmark)
• Eli Lilly and Company (U.S.)
• Sanofi (France)
• Biocon (India)
• Lupin (India)
• Shanghai Fosun Wanbang (Jiangsu)
• Pharmaceutical Group Co., Ltd. (China)
• Diasome Pharmaceuticals, Inc. (U.S.)
• SciGen Pte. Ltd. (Singapore)
• Wockhardt (India)
• MJ Biopharma Pvt. Ltd. (India)
• Oramed Pharmaceuticals (U.S.)
• Adocia (France)
• Nektar Therapeutics (U.S.)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Global Oral Insulin Market For Type 1 And Type 2 Diabetes; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters Five Forces Analysis; 4.3 Epidemiology; 4.4 Industry Insights; 4.5 Key Marketing Strategies For The Global Oral Insulin Market (Type 1 & Type 2 Diabetes); 4.6 Mergers And Acquisition; 4.7 Pipeline Anlysis
5 Regulatory: 5.1 Regulatory Framework For The Asia-pacific Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.1.1 Regulatory Approval Process; 5.1.2 Geographies’ Ease Of Regulatory Approval; 5.1.3 Regulatory Approval Pathways (Country-wise); 5.1.4 Licensing And Registration; 5.1.5 Post-marketing Surveillance; 5.1.6 Good Manufacturing Practices (Gmps) Guidelines; 5.2 Regulatory Framework For The North America Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.2.1 Regulatory Approval Process; 5.2.2 Geographies’ Ease Of Regulatory Approval; 5.2.3 Regulatory Approval Pathways (Country-wise); 5.2.4 Licensing And Registration; 5.2.5 Post-marketing Surveillance; 5.2.6 Good Manufacturing Practices (Gmps) Guidelines; 5.3 Regulatory Framework For The South America Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.3.1 Regulatory Approval Process; 5.3.2 Geographies’ Ease Of Regulatory Approval; 5.3.3 Regulatory Approval Pathways (Country-wise); 5.3.4 Licensing And Registration; 5.3.5 Post-marketing Surveillance; 5.3.6 Good Manufacturing Practices (Gmps) Guidelines; 5.4 Regulatory Framework For The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.4.1 Regulatory Approval Process; 5.4.2 Geographies’ Ease Of Regulatory Approval; 5.4.3 Regulatory Approval Pathways (Country-wise); 5.4.4 Licensing And Registration; 5.4.5 Post-marketing Surveillance; 5.4.6 Good Manufacturing Practices (Gmps) Guidelines; 5.5 Regulatory Framework For The Middle East & Africa (Mea) Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.5.1 Regulatory Approval Process; 5.5.2 Geographies’ Ease Of Regulatory Approval; 5.5.3 Regulatory Approval Pathways (Country-wise); 5.5.4 Licensing And Registration; 5.5.5 Post-marketing Surveillance; 5.5.6 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Incidence Of Diabetes Worldwide; 6.1.2 Growing Geriatric Population Encouraging Demand For Non-invasive Diabetes Solutions; 6.1.3 Advancements In Oral Insulin Formulations; 6.1.4 Enhanced Patient Compliance And Convenience With Oral Insulin; 6.2 Restraints; 6.2.1 Adverse Effects Of High Dosage Of Insulin; 6.2.2 High Production And Development Costs Associated With Insulin; 6.3 Opportunities; 6.3.1 Advancements In Oral Insulin Delivery Technologies; 6.3.2 Revolutionizing Diabetes Management With Needle-free Oral Insulin; 6.3.3 Increasing Pharmaceutical Investments And Strategic Collaborations; 6.4 Challenges; 6.4.1 Insulin Accessibility Challenges In Rural And Underserved Regions; 6.4.2 Limited Shelf Life Associated With Oral Insulin
7 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Type: 7.1 Overview; 7.2 Type 2 Diabetes; 7.3 Type 1 Diabetes
8 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Technology: 8.1 Overview; 8.2 Polymeric Nanoparticles; 8.3 Nanoparticle-based Delivery Systems; 8.4 Encapsulation Technology; 8.5 Lipid-based Nanocarriers
9 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Product Type: 9.1 Overview; 9.2 Capsules
10 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Absorption Site: 10.1 Overview; 10.2 Intestinal
11 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Formulation Type: 11.1 Overview; 11.2 Enteric-coated Oral Insulin
12 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Age Group: 12.1 Overview; 12.2 Adult Patients; 12.3 Geriatric Patients; 12.4 Pediatric Patients
13 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Gender: 13.1 Overview; 13.2 Male; 13.3 Female
14 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Distribution Channel: 14.1 Overview; 14.2 Retail Pharmacies; 14.3 Hospital Pharmacies; 14.4 Online Pharmacies; 14.5 Diabetes Clinics & Specialty Pharmacies
15 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region: 15.1 Overview; 15.2 North America; 15.2.1 U.S.; 15.2.2 Canada; 15.2.3 Mexico; 15.3 Europe; 15.3.1 Germany; 15.3.2 France; 15.3.3 U.K.; 15.3.4 Italy; 15.3.5 Russia; 15.3.6 Spain; 15.3.7 Turkey; 15.3.8 Netherland; 15.3.9 Switzerland; 15.3.10 Austria; 15.3.11 Ireland; 15.3.12 Norway; 15.3.13 Poland; 15.4 Asia-pacific; 15.4.1 China; 15.4.2 India; 15.4.3 Japan; 15.4.4 South Korea; 15.4.5 Australia; 15.4.6 Indonesia; 15.4.7 Thailand; 15.4.8 Malaysia; 15.4.9 Vietnam; 15.4.10 Philippines; 15.4.11 Taiwan; 15.4.12 Singapore; 15.5 South America; 15.5.1 Brazil; 15.5.2 Argentina; 15.6 Middle East And Africa; 15.6.1 Saudi Arabia
16 Company Profile: 16.1 Aphios Corporation; 16.1.1 Company Snapshot; 16.1.2 Pipeline Portfolio; 16.1.3 Recent Updates; 16.2 Biocon; 16.2.1 Company Snapshot; 16.2.2 Revenue Analysis; 16.2.3 Pipeline Product Portfolio; 16.2.4 Recent Development; 16.3 Diabetology Ltd; 16.3.1 Company Snapshot; 16.3.2 Pipeline Portfolio; 16.3.3 Recent Updates; 16.4 Endo Axiom; 16.4.1 Company Snapshot; 16.4.2 Pipeline Portfolio; 16.4.3 Recent Developments; 16.5 Murli Krishna Pharma; 16.5.1 Company Snapshot; 16.5.2 Pipeline Portfolio; 16.5.3 Recent Updates; 16.6 Niedlfree; 16.6.1 Company Snapshot; 16.6.2 Pipeline Portfolio; 16.6.3 Recent Updates; 16.7 Oramed; 16.7.1 Company Snapshot; 16.7.2 Revenue Analysis; 16.7.3 Pipeline Product Portfolio; 16.7.4 Recent Development; 16.8 Transgene Biotek Limited; 16.8.1 Company Snapshot; 16.8.2 Revenue Analysis; 16.8.3 Pipeline Portfolio; 16.8.4 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables: Table 1 Global Clinical Trial Market For Oral Insulin Market For Type 1 And Type 2 Diabetes; Table 2 Distribution Of Products And Projects By Phase Global Oral Insulin Market For Type 1 And Type 2 Diabetes; Table 3 Distribution Of Projects By Therapeutic Area And Phase Global Oral Insulin Market For Type 1 And Type 2 Diabetes; Table 4 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Type, 2018-2032 (Usd Thousand); Table 5 Global Type 2 Diabetes In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 6 Global Type 1 Diabetes In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 7 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Technology, 2018-2032 (Usd Thousand); Table 8 Global Polymeric Nanoparticles In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 9 Global Nanoparticle-based Delivery Systems In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 10 Global Encapsulation Technology In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 11 Global Lipid-based Nanocarriers In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 12 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Product Type, 2018-2032 (Usd Thousand); Table 13 Global Capsules In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 14 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Product Type, 2018-2032 (Usd Thousand); Table 15 Global Intestinal In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 16 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Formulation Type, 2018-2032 (Usd Thousand); Table 17 Global Enteric-coated Oral Insulin In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 18 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Age Group, 2018-2032 (Usd Thousand); Table 19 Global Adult Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 20 Global Geriatric Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 21 Global Pediatric Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 22 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Gender, 2018-2032 (Usd Thousand); Table 23 Global Male In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 24 Global Female In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 25 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Distribution Channel, 2018-2032 (Usd Thousand); Table 26 Global Retail Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 27 Global Hospital Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 28 Global Online Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 29 Global Diabetes Clinics & Specialty Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 30 Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2022-2031 (Usd Million); Table 31 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand); Table 32 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand); Table 33 Asia-pacific Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand); Table 34 South America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand); Table 35 Middle East And Africa Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand)
List Of Figures: Figure 1 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Segmentation; Figure 2 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Data Triangulation; Figure 3 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Droc Analysis; Figure 4 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Global Vs Regional Market Analysis; Figure 5 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Company Research Analysis; Figure 6 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Interview Demographics; Figure 7 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Dbmr Market Position Grid; Figure 8 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Segmentation; Figure 9 Global Oral Insulin Market For Type 1 And Type 2 Diabetes Executive Summary; Figure 10 Strategic Decisions; Figure 11 Two Segments Comprise The Global Oral Insulin Market For Type 1 And Type 2 Diabetes, By Type; Figure 12 Growing Incidence Of Diabetes Worldwide Is Expected To Drive The Global Oral Insulin Market For Type 1 And Type 2 Diabetes Growth In The Forecast Period Of 2026 To 2032; Figure 13 Type 2 Segment Is Expected To Account For The Largest Share Of The Global Oral Insulin Market For Type 1 And Type 2 Diabetes In The Forecast Period Of 2026 & 2032; Figure 14 North Ameirca Is Expected To Dominate The Global Oral Insulin Market For Type 1 And Type 2 Diabetes, And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period Of 2026 To 2032; Figure 15 Asia-pacific Is The Fastest-growing Market For Global Oral Insulin Market For Type 1 And Type 2 Diabetes In The Forecast Period Of 2026 To 2032; Figure 16 Top 10 Countries By The Number Of Adults With Diabetes In 2021; Figure 17 Global Healthcare Expenditure For Diabetes; Figure 18 Number Of People With Diabetes In 2045 (Millions); Figure 19 Droc Analysis; Figure 20 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, 2024; Figure 21 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, 2025 To 2032 (Usd Thousand); Figure 22 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, Cagr (2025- 2032); Figure 23 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, Lifeline Curve; Figure 24 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, 2024; Figure 25 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, 2025 To 2032 (Usd Thousand); Figure 26 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, Cagr (2025- 2032); Figure 27 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, Lifeline Curve; Figure 28 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, 2024; Figure 29 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, 2025 To 2032 (Usd Thousand); Figure 30 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, Cagr (2025- 2032); Figure 31 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, Lifeline Curve; Figure 32 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, 2024; Figure 33 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, 2025 To 2032 (Usd Thousand); Figure 34 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, Cagr (2025- 2032); Figure 35 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, Lifeline Curve; Figure 36 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, 2024; Figure 37 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, 2025 To 2032 (Usd Thousand); Figure 38 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, Cagr (2025- 2032); Figure 39 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, Lifeline Curve; Figure 40 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, 2024; Figure 41 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, 2025 To 2032 (Usd Thousand); Figure 42 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, Cagr (2025- 2032); Figure 43 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, Lifeline Curve; Figure 44 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, 2024; Figure 45 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, 2025 To 2032 (Usd Thousand); Figure 46 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, Cagr (2025- 2032); Figure 47 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, Lifeline Curve; Figure 48 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, 2024; Figure 49 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, 2025 To 2032 (Usd Thousand); Figure 50 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, Cagr (2025- 2032); Figure 51 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, Lifeline Curve; Figure 52 Global Oral Insulin Market For Type 1 And Type 2 Diabetes: Snapshot

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now